# Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant

> **NCT07050160** · — · ENROLLING_BY_INVITATION · sponsor: **Lexeo Therapeutics** · enrollment: 10 (estimated)

## Conditions studied

- Arrhythmogenic Cardiomyopathy
- PKP2-ACM
- PKP2-ARVC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07050160
- **Lead sponsor:** Lexeo Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-08-29
- **Primary completion:** 2030-08
- **Final completion:** 2030-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07050160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07050160, "Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07050160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*